PMID- 37071203
OWN - NLM
STAT- MEDLINE
DCOM- 20230823
LR  - 20230828
IS  - 1613-7671 (Electronic)
IS  - 0043-5325 (Print)
IS  - 0043-5325 (Linking)
VI  - 135
IP  - 15-16
DP  - 2023 Aug
TI  - Management of suspected and known eosinophilic esophagitis-a nationwide survey in 
      Austria.
PG  - 406-413
LID - 10.1007/s00508-023-02198-0 [doi]
AB  - INTRODUCTION: Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease 
      of the esophagus with increasing incidence and dysphagia as the main symptom. The 
      management of suspected or known EoE by Austrian endoscopists has not been 
      investigated yet. METHODS: A web-based survey with 13 questions about the 
      management of EoE was sent to endoscopists via the Austrian Society of 
      Gastroenterology and Hepatology (OGGH). RESULTS: A total of 222 endoscopists (74% 
      gastroenterologists, 23% surgeons, and 2% pediatricians; 68% working in 
      a hospital) from all 9 states participated. In patients with dysphagia but 
      a normal appearing esophagus, 85% of respondents reported always taking biopsies; 
      however, surgeons were less likely to obtain biopsies compared to 
      gastroenterologists ("always" 69% vs. 90%, "sometimes" 29% vs. 10%, "never" 2% 
      vs. 0%, p < 0.001). The approved budesonide orodispersible tablet is the 
      preferred first-line drug used in EoE, ahead of proton pump inhibitors (PPI). 
      Only 65% of participants monitor the patients by endoscopy and histology after 
      12 weeks of induction therapy, 26% do not continue maintenance therapy, and 22% 
      monitor patients only when symptomatic. CONCLUSION: The vast majority of Austrian 
      endoscopists adhere to the European and US guidelines in cases of suspected EoE. 
      In contrast, despite the chronic disease course, a significant percentage of 
      providers indicate not to use maintenance therapy and monitor the patients 
      routinely.
CI  - (c) 2023. The Author(s).
FAU - Schreiner, Philipp
AU  - Schreiner P
AUID- ORCID: 0000-0003-1610-1925
AD  - Division of Gastroenterology and Hepatology, Department of Internal Medicine III, 
      Medical University of Vienna, Vienna, Austria. 
      philipp.schreiner@meduniwien.ac.at.
FAU - Balcar, Lorenz
AU  - Balcar L
AD  - Division of Gastroenterology and Hepatology, Department of Internal Medicine III, 
      Medical University of Vienna, Vienna, Austria.
FAU - Schlager, Hansjorg
AU  - Schlager H
AD  - Division of Gastroenterology and Hepatology, Department of Internal Medicine, 
      Medical University of Graz, University Hospital Graz, Graz, Austria.
FAU - Madl, Christian
AU  - Madl C
AD  - Division of Gastroenterology and Hepatology, Krankenanstalt Rudolfstiftung, 
      Vienna, Austria.
FAU - Ziachehabi, Alexander
AU  - Ziachehabi A
AD  - Department of Internal Medicine II, Kepler Universitatsklinikum, Linz, Austria.
FAU - Mader, Markus
AU  - Mader M
AD  - Department of Internal Medicine II, Universitatsklinikum St. Polten, St. Polten, 
      Austria.
FAU - Steidl, Karin
AU  - Steidl K
AD  - Department of Internal Medicine, Hospital Brothers of Mercy, St. Veit an der 
      Glan, Austria.
FAU - Dinkhauser, Patrick
AU  - Dinkhauser P
AD  - Department of Internal Medicine I, Division of Gastroenterology and Hepatology, 
      Endocrinology and Rheumatology, Klinikum Wels-Grieskirchen, Wels, Austria.
FAU - Reider, Simon
AU  - Reider S
AD  - Department of Internal Medicine 2 (Gastroenterology and Hepatology), Faculty of 
      Medicine, Kepler University Hospital, Johannes Kepler University, Linz, Austria.
FAU - Dolak, Werner
AU  - Dolak W
AD  - Division of Gastroenterology and Hepatology, Department of Internal Medicine III, 
      Medical University of Vienna, Vienna, Austria.
FAU - Dejaco, Clemens
AU  - Dejaco C
AD  - Division of Gastroenterology and Hepatology, Department of Internal Medicine III, 
      Medical University of Vienna, Vienna, Austria.
FAU - Grochenig, Hans Peter
AU  - Grochenig HP
AD  - Department of Internal Medicine, Hospital Brothers of Mercy, St. Veit an der 
      Glan, Austria.
FAU - Novacek, Gottfried
AU  - Novacek G
AD  - Division of Gastroenterology and Hepatology, Department of Internal Medicine III, 
      Medical University of Vienna, Vienna, Austria.
LA  - eng
PT  - Journal Article
DEP - 20230418
PL  - Austria
TA  - Wien Klin Wochenschr
JT  - Wiener klinische Wochenschrift
JID - 21620870R
RN  - 0 (Proton Pump Inhibitors)
RN  - Eosinophilic enteropathy
SB  - IM
MH  - Humans
MH  - *Eosinophilic Esophagitis/diagnosis/epidemiology/therapy
MH  - *Deglutition Disorders/drug therapy/etiology
MH  - Austria
MH  - Surveys and Questionnaires
MH  - Proton Pump Inhibitors/therapeutic use
PMC - PMC10444684
OTO - NOTNLM
OT  - Dysphagia
OT  - Esophageal Disease
OT  - Esophageal Food Impaction
OT  - Inflammatory Bowel Disease
OT  - Swallowing Disorder
COIS- P. Schreiner received consulting fees from Falk Pharma, Sanofi, Galapagos, 
      Pfizer, Takeda, Abbvie, Janssen-Cilag and Ferring. H. Schlager received 
      consulting fees from Falk Pharma and MedTronic. G. Novacek has received 
      consulting fees from AbbVie, MSD, Takeda, Janssen, Sandoz, Pfizer, Astro Pharma, 
      Falk Pharma, Ferring, Gilead, Galapagos and Vifor. L. Balcar, C. Madl, 
      A. Ziachehabi, M. Mader, K. Steidl, P. Dinkhauser, S. Reider, W. Dolak, 
      C. Dejaco, and H. P. Grochenig declare that they have no competing interests.
EDAT- 2023/04/19 06:00
MHDA- 2023/08/23 06:42
PMCR- 2023/04/18
CRDT- 2023/04/18 11:16
PHST- 2023/01/28 00:00 [received]
PHST- 2023/03/19 00:00 [accepted]
PHST- 2023/08/23 06:42 [medline]
PHST- 2023/04/19 06:00 [pubmed]
PHST- 2023/04/18 11:16 [entrez]
PHST- 2023/04/18 00:00 [pmc-release]
AID - 10.1007/s00508-023-02198-0 [pii]
AID - 2198 [pii]
AID - 10.1007/s00508-023-02198-0 [doi]
PST - ppublish
SO  - Wien Klin Wochenschr. 2023 Aug;135(15-16):406-413. doi: 
      10.1007/s00508-023-02198-0. Epub 2023 Apr 18.